Castle Biosciences
CSTL----
Castle Biosciences (CSTL)
Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Castle Biosciences Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$42.7873.29%
Forecast & RatingStrong buy
9analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · 20 hours ago
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of "Moderate Buy" by Analysts
- StockTitan · Jul 14 at 07:30 AM
Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test | CSTL Stock News
- StockTitan · Jul 8 at 10:00 PM
Castle Biosciences to Release Second Quarter 2026 Financial Results and Host Webcast on Thursday, July 30, 2026 | CSTL Stock News
- PUBT · Jul 6 at 03:25 PM
Castle Biosciences COO Kristen Oelschlager sells 8,586 shares for $209,041.2
- Market Beat · Jun 28 at 05:24 AM
Castle Biosciences, Inc. $CSTL Shares Sold by Wasatch Advisors LP
- PUBT · Jun 25 at 03:30 PM
Castle Biosciences says DecisionDx-Melanoma i31-SLNB beats MIA nomogram in prospective SLNB risk study
